In a randomized, double-blind, placebo-controlled crossover trial (n = 11) we tested the hypothesis that acutely raising β-OHB by ingestion of exogenous ketones would attenuate NLRP3 activation in humans with obesity. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.